Tech Company Financing Transactions
Thar Pharmaceuticals Funding Round
Private investors participated in a $2 million funding round for Thar Pharmaceuticals. This venture round was announced by the company on 11/13/2013.
Transaction Overview
Company Name
Announced On
11/13/2013
Transaction Type
Debt
Amount
$1,990,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Please contact technology company for solicitation details, if applicable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
150 Gamma Dr.
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
Thar Pharmaceuticals is focused on the identification and development of new forms of widely prescribed drugs that solve clinical opportunities such as improved bioavailability, efficacy, absorption, safety or toxicity. It is estimated that the clinical performance of seventy percent of currently marketed drugs can be improved.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lalit Chordia
Chief Executive Officer
Raymond Houck
Chief Medical Officer
Ira Kalfus
VP - Regulatory Affairs
Jason Bablak
Browse more venture capital transactions:
Prev: 11/13/2013: introNetworks venture capital transaction
Next: 11/13/2013: Ombitron venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs